ロード中...
Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke
Metformin is currently the first-line treatment drug for type 2 diabetes. Metformin is a well-known activator of AMP-activated protein kinase (AMPK). In experimental studies, metformin has been shown to exert direct vascular effects by increasing vascular endothelial growth factor expression and imp...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4061245/ https://ncbi.nlm.nih.gov/pubmed/24649970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejn.12556 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|